Expertise in
6
conditions

Dr. Gail Torkildsen

Ophthalmology
Andover Eye Associates Inc.
138 Haverhill St Ste 104, 
Andover, MA 
Expertise in
6
conditions
Andover Eye Associates Inc.
138 Haverhill St Ste 104, 
Andover, MA 

Overview

Gail Torkildsen is an Ophthalmologist in Andover, Massachusetts. Dr. Torkildsen is highly rated in 6 conditions, according to our data. Her top areas of expertise are Giant Papillary Conjunctivitis, Vernal Keratoconjunctivitis, Allergic Conjunctivitis, and Chemosis.

Her clinical research consists of co-authoring 25 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Ophthalmology

Licenses

Ophthalmology in MA

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Tufts
  • HMO

Locations

Andover Eye Associates Inc.
138 Haverhill St Ste 104, Andover, MA 01810

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Multicenter, Double-Masked Evaluation of the Safety and Effectiveness of Aceclidine /Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia
A Multicenter, Double-Masked Evaluation of the Safety and Effectiveness of Aceclidine /Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia
Enrollment Status: Completed
Publish Date: September 05, 2024
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2b Study Evaluating the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry Eye Disease (COMET-1)
A Phase 2b Study Evaluating the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry Eye Disease (COMET-1)
Enrollment Status: Completed
Publish Date: August 28, 2024
Intervention Type: Drug
Study Drugs: AR15512, Vehicle
Study Phase: Phase 2
Randomized, Controlled, Multicenter, Double-Masked, Parallel, Phase 2b/3 Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis
Randomized, Controlled, Multicenter, Double-Masked, Parallel, Phase 2b/3 Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis
Enrollment Status: Completed
Publish Date: December 21, 2023
Intervention Type: Drug
Study Drug: Lotilaner Ophthalmic Solution
Study Phase: Phase 2/Phase 3
A Single-Center, Randomized, Double Masked, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of iNexin™ Eye Drops Compared to Vehicle in Subjects With Dry Eye Disease
A Single-Center, Randomized, Double Masked, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of iNexin™ Eye Drops Compared to Vehicle in Subjects With Dry Eye Disease
Enrollment Status: Completed
Publish Date: March 04, 2022
Intervention Type: Drug
Study Phase: Phase 1
A Phase 2, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of Three Different Concentrations (0.1%, 1.0%, 5.0%) of SAR 1118 Ophthalmic Solution in Subjects With Dry Eye Using the Controlled Adverse Environment (CAE) Model
A Phase 2, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of Three Different Concentrations (0.1%, 1.0%, 5.0%) of SAR 1118 Ophthalmic Solution in Subjects With Dry Eye Using the Controlled Adverse Environment (CAE) Model
Enrollment Status: Completed
Publish Date: August 09, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2, Single Center, Randomized, Double-Masked and Placebo Controlled Study Evaluating the Efficacy of Three Different Concentrations (0.1, 1.0, 5.0%) of SAR 1118 Ophthalmic Solution in a Modified Conjunctival Allergen Challenge (CAC) Model
A Phase 2, Single Center, Randomized, Double-Masked and Placebo Controlled Study Evaluating the Efficacy of Three Different Concentrations (0.1, 1.0, 5.0%) of SAR 1118 Ophthalmic Solution in a Modified Conjunctival Allergen Challenge (CAC) Model
Enrollment Status: Completed
Publish Date: June 11, 2021
Intervention Type: Drug, Other
Study Phase: Phase 2
View 5 Less Clinical Trials

25 Total Publications

Efficacy and Safety of the Melanocortin Pan-Agonist PL9643 in a Phase 2 Study of Patients with Dry Eye Disease.
Efficacy and Safety of the Melanocortin Pan-Agonist PL9643 in a Phase 2 Study of Patients with Dry Eye Disease.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: September 07, 2023
Similar Doctors
Expertise in
27
conditions
Dr. Jeffrey Heier
Ophthalmology
Expertise in
27
conditions
Dr. Jeffrey Heier
Ophthalmology

Ophthalmic Consultants Of Boston Inc

50 Staniford St Ste 600, 
Boston, MA 
 (22.0 miles away)
617-367-4800
Languages Spoken:
English
See accepted insurances

Jeffrey Heier is an Ophthalmologist in Boston, Massachusetts. Dr. Heier is highly rated in 27 conditions, according to our data. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Retinal Vein Occlusion, and Vitrectomy.

Expertise in
19
conditions
Dr. Eric Pierce
Ophthalmology
Expertise in
19
conditions
Dr. Eric Pierce
Ophthalmology

Massachusetts Eye And Ear

243 Charles St, 
Boston, MA 
 (21.9 miles away)
617-573-3621
Languages Spoken:
English
See accepted insurances

Eric Pierce is an Ophthalmologist in Boston, Massachusetts. Dr. Pierce is highly rated in 19 conditions, according to our data. His top areas of expertise are Retinopathy Pigmentary Mental Retardation, Retinitis Pigmentosa, Doyne Honeycomb Retinal Dystrophy, and Late-Onset Retinal Degeneration.

Expertise in
25
conditions
Dr. Demetrios Vavvas
Ophthalmology
Expertise in
25
conditions
Dr. Demetrios Vavvas
Ophthalmology

Massachusetts Eye And Ear

243 Charles St, 
Boston, MA 
 (21.9 miles away)
617-573-6874
Languages Spoken:
English
See accepted insurances

Demetrios Vavvas is an Ophthalmologist in Boston, Massachusetts. Dr. Vavvas is highly rated in 25 conditions, according to our data. His top areas of expertise are Retinal Detachment, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

Frequently Asked Questions about Dr. Gail Torkildsen

How do I make an appointment with Dr. Gail Torkildsen?

You can book an appointment with Dr. Gail Torkildsen by calling their office at 978-475-0705. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Gail Torkildsen a top-rated expert for Giant Papillary Conjunctivitis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gail Torkildsen is classified as an Elite expert for Giant Papillary Conjunctivitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Gail Torkildsen specialize in?

While Dr. Gail Torkildsen is a Ophthalmology, they have specific expertise in Giant Papillary Conjunctivitis, Vernal Keratoconjunctivitis, and Allergic Conjunctivitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.

Does Dr. Gail Torkildsen participate in research or clinical trials?

Yes. Dr. Gail Torkildsen has published 25 articles and abstracts on conditions like Giant Papillary Conjunctivitis. You can view a list of Dr. Gail Torkildsen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Gail Torkildsen accept my insurance?

Dr. Gail Torkildsen accepts most major insurance plans, including Anthem BCBS and Medicare. We recommend calling the office directly at 978-475-0705 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Torkildsen's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile